Warning on risks: Financial contracts for difference are complex instruments and are associated with a high risk of rapid financial losses due to leverage. On 72.29% of retail investor accounts, financial losses occur when trading financial contracts for difference with this provider. You should consider whether you understand how financial contracts for difference work, and whether you can afford to take the high risk of suffering financial losses. Please read the Risk Disclosures.

Logo icon

Market analysis and news

Get an overview of current market developments with regular analysis from our analysts. We offer a detailed view of key events, economic indicators and investment opportunities. Follow the development of the markets with us and make decisions based on data and experience.

16/5/2022
The Bear Market of 2022: Be Smart, Be Cautious.
"We live in the most chaotic, hard-to-predict macroeconomic times in decades. The ingredients for a global recession are on the table". These were the daunting analyst notes of Seth Carpenter, which leads Morgan Stanley’s bank strategists. Inflation is at its highest in decades and macroeconomic instabilities are mounting.
More
26/4/2022
Current impact of the pandemic on the world economy
It is impossible to talk about the global economic outlook to 2022 without addressing inflation. For decades, significant price increases have eluded most major markets. However, the World Economic Situation and Prospects (WESP) 2022 outlook warns that global economic recovery depends on balance amid new waves of COVID-19 disease, labour market challenges, persistent supply chain constraints and rising inflationary pressures. Overall economic optimism also continues to decline due to the geopolitical situation between Ukraine and Russia.
More
22/3/2022
What effect does current war have on pharmaceutical companies?
War has had a negative effect on most sectors so far, with the only sector that seems like it has been profiting from it are oil and gas companies. One sector that is also expected to get hit hard is pharmaceutical companies. Ukraine and Russia are countries, where many of them were doing trials, importing medicines, etc., which will be almost impossible for at least until the end of the war. In Ukraine it will not be possible to do any trials because of the geopolitical situation going on there and in Russia, of course, because of sanctions. In this analysis we will check, which companies are expected to get hit the hardest as well as what impact happened in history.
More
23/2/2022
HOW PHARMACEUTICS ARE DOING THIS YEAR
Pharmaceutical industry is one of the biggest industries in the world. It is also fast and constantly growing sector, as it increased from valuation of 390 billion U.S. dollars in 2001 to the total global market valuation at 1,27 trillion U.S. dollars in 2020. With its constant uptrend, it is projected that industry will be worth 1,70 trillion U.S. dollars by the end of 2025. 
More

Latest analyses